Tobin Schilke Insider Trading $RVNC Revance Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Tobin Schilke.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Tobin Schilke. Tobin Schilke is Chief Financial Officer in Achaogen Inc ($AKAO) and CFO in Revance Therapeutics, Inc. ($RVNC).

Tobin Schilke in Revance Therapeutics, Inc.

Trading Symbol: RVNC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Tobin Schilke: CFO
Holdings: 70,735 shares
Current Value: $1,464,215
Latest Transaction: Feb 19 2021
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Tobin Schilke in Revance Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKAO, RVNC

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 19 2021	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Payment of Exercise	F	28.97	1,973	57,158	68,762	70.7 K to 68.8 K (-2.79 %)
Feb 19 2021	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Payment of Exercise	F	28.97	684	19,815	70,735	71.4 K to 70.7 K (-0.96 %)
Feb 04 2021	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Option Exercise	A	28.01	40,925	1,146,309	40,925
Feb 04 2021	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Grant	A	0.00	22,620	0	71,419	48.8 K to 71.4 K (+46.35 %)
Jan 04 2021	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Buy	J	21.36	493	10,531	48,799	48.3 K to 48.8 K (+1.02 %)
Dec 22 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Payment of Exercise	F	26.75	1,556	41,623	48,306	49.9 K to 48.3 K (-3.12 %)
Oct 02 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Payment of Exercise	F	25.14	5,446	136,912	49,862	55.3 K to 49.9 K (-9.85 %)
Oct 02 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Grant	A	0.00	15,750	0	55,308	39.6 K to 55.3 K (+39.81 %)
Jul 02 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Buy	J	13.80	763	10,526	39,558	38.8 K to 39.6 K (+1.97 %)
Feb 19 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Payment of Exercise	F	25.33	576	14,590	38,795	39.4 K to 38.8 K (-1.46 %)
Jan 24 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Option Exercise	A	22.32	97,500	2,176,200	97,500
Jan 24 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Grant	A	0.00	16,500	0	39,371	22.9 K to 39.4 K (+72.14 %)
Jan 03 2020	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Buy	J	10.82	504	5,453	22,871	22.4 K to 22.9 K (+2.25 %)
Dec 17 2019	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Payment of Exercise	F	15.99	1,556	24,880	22,367	23.9 K to 22.4 K (-6.50 %)
Jul 02 2019	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Buy	J	11.02	923	10,176	23,923	23 K to 23.9 K (+4.01 %)
Jan 25 2019	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Option Exercise	A	17.23	30,000	516,900	30,000
Jan 25 2019	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Grant	A	0.00	5,000	0	23,000	18 K to 23 K (+27.78 %)
Nov 07 2018	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Option Exercise	A	24.96	100,000	2,496,000	100,000
Nov 07 2018	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Grant	A	0.00	18,000	0	18,000	0 to 18 K
Nov 07 2018	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Option Exercise	A	24.96	100,000	2,496,000	100,000
Nov 07 2018	RVNC	Revance Therapeuti ...	Schilke Tobin	CFO	Grant	A	0.00	18,000	0	18,000	0 to 18 K

Page: 1